Statera Biopharma, Inc.
Statera Biopharma, Inc. (STAB) Stock Forecast & Price Predictions
Get the latest Statera Biopharma, Inc. (STAB) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Statera Biopharma, Inc. Stock Forecast Summary
Statera Biopharma, Inc. (STAB) stock is currently priced at $0.00. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $0.00.
In the long term, STAB shows a bullish trend. The 2027 forecast points to $0.01 (2106.52% change), while the 2031 forecast suggests $0.00 (-100.00% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.
Neutral
Bearish
Bullish
This mix indicates that Statera Biopharma, Inc. stock is expected to rise steadily over the coming years.
Statera Biopharma, Inc. yearly Price Forecast Chart
Explore the yearly forecast chart for STAB, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Statera Biopharma, Inc. over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for STABForecasting details for STAB are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Statera Biopharma, Inc. Stock Forecast 2026
The forecast for Statera Biopharma, Inc. (STAB) in 2026 suggests a price of $0.01, representing a 2106.52% move from today’s price.
Average Target: $0.01
Market Outlook: bullish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Healthcare.
- Macroeconomic factors such as interest rates and inflation.